|
SMARCD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.584030E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.397000E-01 |
| Normal-vs-Stage2 |
8.256000E-03 |
| Normal-vs-Stage3 |
3.001500E-02 |
| Normal-vs-Stage4 |
3.636000E-01 |
| Stage1-vs-Stage2 |
1.513910E-02 |
| Stage1-vs-Stage3 |
3.180000E-02 |
| Stage1-vs-Stage4 |
6.929800E-01 |
| Stage2-vs-Stage3 |
4.672400E-01 |
| Stage2-vs-Stage4 |
5.011800E-02 |
| Stage3-vs-Stage4 |
1.679160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.013780E-01 |
| Normal-vs-AfricanAmerican |
9.143800E-01 |
| Normal-vs-Asian |
9.159600E-02 |
| Caucasian-vs-AfricanAmerican |
1.874770E-01 |
| Caucasian-vs-Asian |
2.910500E-02 |
| AfricanAmerican-vs-Asian |
1.383400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.403970E-01 |
| Normal-vs-Female |
2.721200E-01 |
| Male-vs-Female |
4.900400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.397400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.560400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.638600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.340500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.888400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.245400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.900600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.180800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.141600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.383170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.600600E-01 |
| Normal-vs-Grade 2 |
4.324600E-01 |
| Normal-vs-Grade 3 |
3.279500E-03 |
| Normal-vs-Grade 4 |
6.385000E-01 |
| Grade 1-vs-Grade 2 |
3.771700E-02 |
| Grade 1-vs-Grade 3 |
8.121200E-03 |
| Grade 1-vs-Grade 4 |
3.282800E-01 |
| Grade 2-vs-Grade 3 |
5.841700E-03 |
| Grade 2-vs-Grade 4 |
1.848170E-01 |
| Grade 3-vs-Grade 4 |
2.456200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.298900E-03 |
| Normal-vs-ccB subtype |
6.984200E-01 |
| ccA subtype-vs-ccB subtype |
4.698400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.666400E-02 |
| Normal-vs-N1 |
3.894100E-02 |
| N0-vs-N1 |
9.858700E-03 |
|
|
